Development of (4-Cyanophenyl)glycine Derivatives as Reversible Inhibitors of Lysine Specific Demethylase 1

Journal of Medicinal Chemistry - United States
doi 10.1021/acs.jmedchem.7b00462
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Chemical Society (ACS)

Related search

Structure Activity Relationship and Modeling Studies of Inhibitors of Lysine Specific Demethylase 1

PLoS ONE
Multidisciplinary
2017English

Identification of JL1037 as a Novel, Specific, Reversible Lysine-Specific Demethylase 1 Inhibitor That Induce Apoptosis and Autophagy of AML Cells

Oncotarget
Oncology
2017English

Mp29-09 Novel Selective Lysine Specific Demethylase 1 Inhibitors Effectively Impair Castration Resistant Prostate Cancer Growth

Journal of Urology
Urology
2018English

Mp83-03 Novel Selective Lysine Specific Demethylase 1 Inhibitors Effectively Impair Castration Resistant Prostate Cancer Growth

Journal of Urology
Urology
2017English

Mp62-03 Novel Selective Lysine-Specific Demethylase 1 Inhibitors and Autophagy Inhibitors Effectively Impair Castration-Resistant Prostate Cancer Growth

Journal of Urology
Urology
2016English

Lysine-Specific Demethylase 2B (KDM2B; JHDM1B)

Science-Business eXchange
2014English

Catalytic Mechanism Investigation of Lysine-Specific Demethylase 1 (LSD1): A Computational Study

PLoS ONE
Multidisciplinary
2011English

8-Substituted Pyrido[3,4-D]pyrimidin-4(3h)-One Derivatives as Potent, Cell Permeable, KDM4 (JMJD2) and KDM5 (JARID1) Histone Lysine Demethylase Inhibitors

English

Development of Homogeneous Nonradioactive Methyltransferase and Demethylase Assays Targeting Histone H3 Lysine 4

Journal of Biomolecular Screening
Molecular MedicinePharmacologyBiochemistryAnalytical ChemistryBiotechnologyDrug Discovery
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy